Sixteen years after my daughter’s tragic death from a sterile IV compounding error, there’s a question that I always ask myself. I know this career path I’ve been on since Emily’s tragic passing is very unconventional, but it… Read More
EJF Presentations at Moffitt Cancer Center
This past Sunday morning, I flew from my previous speaking engagement in New Orleans, at the National Infusion Center Association (NICA)2022 Annual Conference, to Tampa for the two presentations I gave at Moffitt Cancer Center on Monday. Everything was all coordinated and hosted by the amazing Risk Management team at Moffitt. It was great to have the opportunity to be able to help them kick off Healthcare Risk Management Week at their world-renowned cancer treatment center!
As many of you are already aware, there are over 100 different types of cancer. Some of them are common, but many are rare and complex, requiring very advanced treatment methods, which unfortunately, provide an increased opportunity for “human error.” Obviously, Moffitt Cancer Center is ALL about saving lives by achieving exceptional outcomes from the treatment of many various types of cancer. This is precisely why I was absolutely elated to learn from their Chief Pharmacy Officer, Kenneth Komorny, that their facility is in the process of implementing a new sterile IV compounding workflow system that helps to eliminate “human error” from creeping into their pharmacy workflow, preventing compounding errors like the one which tragically occurred with my daughter Emily in 2006. For these reasons, I am totally convinced that Moffitt is making patient & medication safety, their #1 priority every single day, with every patient!!